-
S-Adenosylmethionine: From Methyl Donor to Translation
2026-09-17
S-Adenosylmethionine, also called Ademetionine or SAMe, is more than a routine methyl donor. It is a metabolic control point linking DNA, RNA, protein, phospholipid, neurotransmitter, and one-carbon biology. This thought-leadership article explains how translational researchers can use SAM to distinguish direct methylation effects from broader metabolic responses, design more interpretable assays, and connect neurological, epigenetic, and liver research without overstating the evidence.
-
Capsaicin: A Mechanism-Split Research Strategy
2026-09-17
Capsaicin is more than a TRPV1 agonist: it can connect sensory signaling with KDM1A biology. This guide explains how to separate itch, pain, inflammation, and gastric cancer readouts for more defensible experiments.
-
How p38α Dephosphorylation Shapes Kinase Inhibition
2026-09-16
The reference preprint shows that selected p38α inhibitors can do more than occupy the kinase active site: they can expose the activation-loop phospho-threonine and accelerate its removal by the phosphatase WIP1. This dual-action mechanism links inhibitor binding to kinase deactivation and offers a structural framework for improving potency and specificity in p38 MAP kinase signaling research.
-
Doxycycline Hyclate: From MMP Signal to BBB Assay
2026-09-15
Doxycycline hyclate is a matrix metalloproteinases inhibitor with practical value in blood–brain barrier and neurotoxicity research. This article translates an arsenic-exposure mouse study into assay-design decisions while distinguishing target engagement, barrier protection, and cross-domain antiviral or antimalarial applications.
-
Saracatinib (AZD0530) Assay Workflow Guide
2026-09-15
Build reproducible Src/Abl pathway experiments with Saracatinib (AZD0530), from dose-response and migration assays to phospho-signaling validation. The workflow also explains how SFK inhibition can be used cautiously to extend Reelin–SFK research into experimentally distinct cancer biology and synaptic models.
-
Western Secondary Antibody Dilution Buffer Workflow
2026-09-14
Build cleaner, more reproducible Western blots for macrophage signaling studies with a stabilizing, reuse-oriented secondary antibody formulation. This workflow connects buffer selection to NHE1, Olfr2, calcium-dependent ROS, and NLRP3 assay design while providing practical optimization and troubleshooting guidance.
-
Eicosapentaenoic Acid (EPA) Workflow Guide
2026-09-14
Build reproducible EPA experiments around two validated concentration windows: low-micromolar oxidation assays and higher-dose endothelial migration models. This practical guide connects membrane remodeling, lipid-lowering studies, and carefully bounded translational insights from recent arachidonic acid immunology research.
-
Artesunate Workflows for Cancer Response Profiling
2026-09-13
Artesunate enables mechanism-aware cancer assays that separate growth suppression from true cell killing. This practical workflow supports small cell lung carcinoma research, esophageal squamous cell carcinoma models, and ferroptosis-oriented studies with controlled dosing, orthogonal readouts, and troubleshooting guidance.
-
Sex Differences in Angiotensin II Hypertension
2026-09-12
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II caused a substantially larger blood-pressure increase in males than females despite comparable baseline pressure. Gonadectomy, baroreflex testing, and ganglionic blockade linked this divergence to sex-dependent hormonal and sympathetic regulation, providing a framework for separating vascular, autonomic, and endocrine contributions to hypertension.
-
Nystatin: Designing Better Antifungal Assays
2026-09-12
Nystatin (Fungicidin) is more than a membrane-active antifungal control: its solubility, species selectivity, and delivery context can reshape assay interpretation. This guide connects Candida phenotyping with nanoparticle uptake research to support more rigorous experimental design.
-
Cefepime: An Evidence-Guided Assay Framework
2026-09-11
Cefepime (BMY-28142) supports a more rigorous approach to central nervous system infection research. This article develops an evidence-guided assay framework that separates direct cefepime findings from transferable lessons in resistant Enterobacterales research.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-11
CAY10499 enables controlled dissection of HSL, MGL, FAAH, and lipid-transmitter pathways in biochemical and cellular models. Its strongest use-case is as an orthogonal lipid-hydrolysis perturbation in EV-driven macrophage studies, where it can distinguish fatty-acid mobilization from ACLY-dependent lipid synthesis.
-
Oseltamivir acid: Mechanism, Models, and Assays
2026-09-10
Oseltamivir acid is an influenza neuraminidase inhibitor suited to mechanism-led antiviral research. This article connects enzyme, cell, resistance, and translational assay design while applying lessons from humanized-mouse prodrug research without conflating distinct metabolic systems.
-
EZ Cap™ Human PTEN mRNA: Mechanism & Workflow
2026-09-10
EZ Cap™ Human PTEN mRNA (ψUTP) is an in vitro transcribed mRNA reagent designed for controlled human PTEN expression in mammalian research models. Its Cap 1 structure, pseudouridine modification, and poly(A) tail support mRNA stability enhancement and translation-focused studies, while published nanoparticle work connects PTEN mRNA delivery with PI3K/Akt signaling pathway inhibition in trastuzumab-resistant breast cancer models.
-
WST-8 Glucose Uptake Assay Kit for NAFLD
2026-09-09
Translate insulin-resistance biology into a quantitative, non-radioactive glucose uptake readout with a workflow suited to hepatocyte and metabolic-stress models. This guide connects Galectin-1–FIP200 autophagy research with practical assay design, normalization, and troubleshooting.